Crystalys Therapeutics
Clinical trials sponsored by Crystalys Therapeutics, explained in plain language.
-
New gout drug aims to beat allopurinol in major trial
Disease control Recruiting nowThis study tests a new medicine called dotinurad to see if it lowers uric acid better than the standard drug allopurinol in adults with gout. About 500 people with frequent gout flares will take either dotinurad or allopurinol for 24 weeks. The main goal is to see how many reach …
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
New gout drug aims to dissolve painful joint lumps
Disease control Recruiting nowThis study tests a new drug called dotinurad against the standard medication allopurinol in 250 adults with tophaceous gout—a severe form of gout with hard lumps under the skin. The main goal is to see if dotinurad lowers uric acid levels more effectively after 24 weeks. Particip…
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:57 UTC